Frankfurt - Delayed Quote
EUR
Zevra Therapeutics, Inc. (1GDA.F)
9.18
+0.10
(+1.10%)
As of 3:42:59 PM GMT+1. Market Open.
Earnings Trends
Earnings Per Share
No Earnings Per Share available for this ticker
Revenue vs. Earnings
Q2 FY26
Revenue
39.66M
Earnings
8.75M
Profit Margin
22.07%
Q3
FY25
Q4
FY25
Q1
FY26
Q2
FY26
0
10M
20M
30M
0.0%
20.0%
40.0%
60.0%
80.0%
100.0%
Revenue Estimate
| Currency in USD
|
Current Qtr. (Sep 2026)
|
Next Qtr. (Dec 2026)
|
Current Year (2026)
|
Next Year (2027)
|
|---|---|---|---|---|
|
No. of Analysts
|
7 | 7 | 7 | 7 |
|
Avg. Estimate
|
37.41M | 40.19M | 153.29M | 177.71M |
|
Low Estimate
|
34.7M | 38.3M | 150M | 151.6M |
|
High Estimate
|
40.91M | 41.9M | 158.63M | 201.96M |
|
Year Ago Sales
|
26.06M | 34.12M | 106.47M | 153.29M |
|
Sales Growth (year/est)
|
43.55% | 17.78% | 43.97% | 15.93% |
Earnings Estimate
| Currency in USD
|
Current Qtr. (Sep 2026)
|
Next Qtr. (Dec 2026)
|
Current Year (2026)
|
Next Year (2027)
|
|---|---|---|---|---|
|
No. of Analysts
|
-- | -- | -- | -- |
|
Avg. Estimate
|
-- | -- | -- | -- |
|
Low Estimate
|
-- | -- | -- | -- |
|
High Estimate
|
-- | -- | -- | -- |
|
Year Ago EPS
|
-- | -- | -- | -- |
EPS Trend
| Currency in USD
|
Current Qtr. (Sep 2026)
|
Next Qtr. (Dec 2026)
|
Current Year (2026)
|
Next Year (2027)
|
|---|---|---|---|---|
|
Current Estimate
|
-- | -- | -- | -- |
|
7 Days Ago
|
-- | -- | -- | -- |
|
30 Days Ago
|
-- | -- | -- | -- |
|
60 Days Ago
|
-- | -- | -- | -- |
|
90 Days Ago
|
-- | -- | -- | -- |
EPS Revisions
| Currency in USD
|
Current Qtr. (Sep 2026)
|
Next Qtr. (Dec 2026)
|
Current Year (2026)
|
Next Year (2027)
|
|---|---|---|---|---|
|
Up Last 7 Days
|
-- | -- | -- | -- |
|
Up Last 30 Days
|
-- | -- | -- | -- |
|
Down Last 7 Days
|
-- | -- | -- | -- |
|
Down Last 30 Days
|
-- | -- | -- | -- |
Growth Estimates
| Symbol | Current Qtr. | Next Qtr. | Current Year | Next Year |
|---|---|---|---|---|
|
1GDA.F
|
-- | -- | -- | -- |
|
S&P 500
|
26.99% | 26.80% | 32.87% | 16.85% |
